Delivery Order SPE2DB22D3301-SPE2DB26FX4JV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,893.47 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials. This non-competitive, firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical procurement within the...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.98 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml vials. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 26, 2025. The award was issued on September 25, 2025, and the pharmaceutical will be delivered to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.3K to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml formulations. This competitively awarded, non-set-aside contract was executed on April 28, 2025, with an ultimate completion date of April 29, 2025, and is priced on a firm fixed-price basis. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,455.97 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. This is a firm fixed price, non-competitive set-aside contract with an ultimate completion date of June 2, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,977.94 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulations. The order was competitively awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a firm fixed-price transaction with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $12,095.40 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL vials. This competitively awarded, firm fixed-price contract is set to conclude on October 24, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single procurement action under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,324.69 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,855.50 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml configurations. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and represents a pharmaceutical delivery to support federal medical procurement needs. The work is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $4,600.97 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulation. Executed on August 26, 2025, with completion targeted for August 27, 2025, this firm fixed-price contract represents a competitively awarded procurement with no set-aside designation. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,921.88 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on August 13, 2025, one day after the award date of August 12, 2025. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4JVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,777.68 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award, made on November 5, 2025, with an ultimate completion date of November 6, 2025, utilizes firm fixed-price pricing under a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this delivery order, which will be performed at the company's Conshohocken facility. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide. The firm's extensive federal contract portfolio demonstrates its capability to fulfill critical medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 11/5/25 |